Olink Holding AB (publ) (NASDAQ:OLK) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Olink Proteomics Q2 2023 Earnings Conference Call. [Operator Instructions].
Olink Holding Ab (Publ) (OLK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | TIG Advisors Carl Tiedemann And Michael Tiedemann | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | ||
| 3. | GLG Partners Noam Gottesman | 0 | $0 | 0% | |
| 4. | Millennium Management Israel Englander | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,127,000 | $204,394,050 | 0.21% | |
| 2. | 2,019,560 | $50,791,934 | 0.01% | |
| 3. | 1,394,867 | $35,080,905 | 0.01% | |
| 4. | 669,967 | $16,849,670 | 0% | |
| 5. | 665,400 | $16,734,810 | 0.92% |
News See All
8 Medical Stocks to Buy According to Mitchell Blutt's Consonance Capital
In this article, we will be looking at the 8 medical stocks to buy according to Mitchell Blutt's Consonance Capital.
Is Olink Holding AB (OLK) A Good Stock To Buy Now?
Baron Discovery Fund recently published its second-quarter commentary – a copy of which can be downloaded here.